| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The evaluation of acid-base status using the Henderson-Hasselbalch equation (Equation 1) has traditionally used the pH value as an overall measure of acid-base status, PCO2 as an independent measure of the respiratory component of acid-base balance, base excess, actual bicarbonate concentration, or standard bicarbonate as a measure of the metabolic (also called nonrespiratory) component of acid-base balance, and calculation of the anion gap to facilitate identification of unmeasured anions or cations in plasma.
So what is wrong with this proven and widely used approach? Simply stated, using the Henderson-Hasselbalch equation to calculate base excess, actual bicarbonate concentration, or standard bicarbonate provides an estimate of the magnitude of a metabolic acidosis and not the mechanism for its development. Thus, the Henderson-Hasselbalch equation cannot satisfactorily explain the mechanism for many acid-base disturbances; hyperchloremic acidosis is one of many clinical conditions that have no rational explanation. It is well recognized that the rapid infusion of large quantities of 0.9% NaCl induces acidemia (hyperchloremic acidosis) and decreases plasma bicarbonate concentration (610) . The Henderson-Hasselbalch equation indicates that hyperchloremic acidosis should be treated by administering bicarbonate in the form of an isotonic solution of sodium bicarbonate:
or the bicarbonate donor tris-hydroxymethyl aminomethane (THAM):
where R-NH2 is THAM, and R-NH3+ is the protonated form of THAM. As shown by Rehm and Finsterer (5), both treatments are effective in restoring bicarbonate concentration and pH to normal. But how does the rapid IV administration of 0.9% NaCl decrease plasma pH and bicarbonate concentration? Is there more to this story? Our understanding of acid-base balance was revolutionized in 1983 by Stewarts development of strong ion theory (4). The strong ion approach has two novel aspects: acid-base balance is examined using a systems approach, and a clear conceptual distinction is made between dependent and independent variables. Independent variables influence a system from the outside and cannot be affected by changes within the system or by changes in other independent variables. In contrast, dependent variables are influenced directly and predictably by changes in the independent variables. Therefore, the strong ion approach offers a clear mechanistic explanation for changes in acid-base balance.
Stewart proposed that plasma pH was determined by three independent factors; PCO2, the strong ion difference (SID), which is the difference between the charge of plasma strong cations (sodium, potassium, calcium, and magnesium) and anions (chloride, lactate, sulfate, ketoacids, nonesterified fatty acids, and many others), in which strong cations and anions are fully dissociated at physiologic pH, and Atot, which is the total plasma concentration of nonvolatile buffers (albumin, globulins, and inorganic phosphate) (4). In this context, pH value and bicarbonate concentration are dependent variables. From the three independent factors (PCO2, SID, and Atot), Stewart developed a complicated polynomial equation that expressed pH value (he erroneously used H+ concentration) as a function of eight factors, consisting of three independent factors and five constants (4). It was subsequently shown, algebraically (11) and graphically (12), that changes in two of Stewarts eight factors had no quantitative effect on pH value, leading to the development of the six-factor simplified strong ion equation in 1997 (11). Currently, the six-factor simplified strong ion equation is the preferred form for applying the strong ion approach (1114) . The equation states that the pH value is a function of three independent factors (PCO2, SID, and Atot) and three constants (S, the apparent dissociation constant for plasma carbonic acid [K1], and Ka, the effective dissociation constant for nonvolatile buffers in plasma), such that:
For those readers that dislike complicated equations, Equation 4 can be expressed in an algebraically simpler but equivalent form as:
Equation 5 simplifies to the Henderson-Hasselbalch equation (Equation 1) in solutions that do not contain protein or phosphate (because Atot = 0 and SID = [HCO3-]). A number of clinical ramifications arise from the simplified strong ion equation (Equation 4). Because clinically important acid-base derangements result from changes in PCO2, SID, or concentrations of individual nonvolatile plasma buffers (Atot; albumin, globulins, and phosphate), the strong ion approach distinguishes six primary acid-base disturbances (respiratory, strong ion, or nonvolatile buffer ion acidosis and alkalosis) instead of the four primary acid-base disturbances (respiratory or metabolic acidosis and alkalosis) differentiated by the traditional Henderson-Hasselbalch equation (1114) . Acidemia results from an increase in PCO2 and nonvolatile buffer concentrations (albumin, globulin, and phosphate) or from a decrease in SID. Alkalemia results from a decrease in PCO2 and nonvolatile buffer concentration or from an increase in SID. The strong ion approach provides an explanation for the development of hyperchloremic acidosis and therefore a rational treatment for this condition. Normal human plasma SID is 42 mEq/L (15), whereas the SID of 0.9% NaCl is 0 mEq/L because sodium and chloride are both strong ions (11). IV administration of 0.9% NaCl must, therefore, decrease plasma SID, which will create a strong ion acidosis (assuming that infusion does not cause a change in PCO2 or plasma albumin, globulin, or phosphate concentrations). The magnitude of the decrease in plasma SID when 0.9% NaCl is administered is dependent upon the relative volumes of the extracellular space and 0.9% NaCl and the speed of the 0.9% NaCl administration. Therefore, hyperchloremic acidosis is easier to detect when large volumes of 0.9% NaCl are rapidly administered, as in the study by Rehm and Finsterer (5).
The following rules of thumb for the clinical assessment of acid-base disturbances in humans have been developed from the simplified strong ion approach: So what new information has application of the strong ion approach provided? Remember that the traditional Henderson-Hasselbalch equation did not describe the mechanism for the development of hyperchloremic acidosis but indicated that hyperchloremic acidosis should be treated with sodium bicarbonate or the bicarbonate donor THAM because bicarbonate concentration was decreased. In contrast, the strong ion approach indicated that hyperchloremic acidosis was caused by the decrease in plasma SID after rapid infusion of large quantities of 0.9% NaCl and that the resultant strong ion acidosis would be best treated by administering a solution with a high effective SID, such as sodium bicarbonate or THAM. For hyperchloremic acidosis, application of the Henderson-Hasselbalch equation and strong ion approaches produced the same treatment (sodium bicarbonate or THAM) but completely different reasons for the response.
Finally, a comment on the method used by Rehm and Finsterer (5) to quantify the unmeasured strong cation concentration in patients receiving THAM, because THAM (R-NH2) is protonated in plasma to R-NH3+, which is a strong cation (see Equation 3). A clinically important problem in sick patients is identifying and quantifying the presence of strong anions or cations in plasma that are not routinely measured including anions such as lactate, ß-hydroxybutyrate, acetoacetate, and anions associated with uremia and cations such as protonated THAM (R-NH3+). Unmeasured strong anion or cation concentrations can be quantified by calculating the anion gap (3), applying the Fencl base excess method (16), calculating the strong ion gap (SIG) using the Figge unmeasured anion method (17,18) , or calculating the SIG using an equation derived from the simplified strong ion equation (19). This equation requires measurement of six variables (pH value, PCO2, [Na], [K], [Cl], and [total protein]) and known species-specific values for Atot and Ka (pKa is the negative logarithm to the base 10 of Ka):
Rehm and Finsterer (5) calculated SIG using the Figge unmeasured anion method (17,18) . It would have been interesting had they calculated SIG using Equation 6 and estimated Atot and pKa values for human plasma (12,19) , whereby:
In Equation 7, SIG and ANION GAP ({[Na+] + [K+]}-{[CI-] + [HCO3-]}) are in units of milliequivalent per liter, and total protein concentration is in units of grams per deciliter. Two milliequivalents per liter was subtracted from the right hand side of Equation 7 because the unmeasured strong cation concentration exceeds the unmeasured strong anion concentration by 23 mEq/L in horse (19) and cattle (20) plasma and presumably by a similar amount in human plasma, although this has not been confirmed. For normal values of pH (7.40), total protein concentration (7.0 g/dL), and anion gap (16 mEq/L when [K+] is included in the calculation, as in Equation 7), Equation 7 calculates that SIG In summary, the strong ion approach provides the clinician with an improved understanding of complex acid-base disturbances and the mechanisms for their development. Because increased understanding will lead to more targeted treatments of acid-base and electrolyte disorders, we are at the dawn of a new era in the treatment of critically ill patients. Exciting times are ahead. Studies by Wilkes (21) in 1998 and Rehm and Finsterer (this journal) are among the first to use the strong ion approach in humans to determine the mechanism for an acid-base disturbance and identify the most appropriate treatment. For hyperchloremic acidosis in healthy patients with normal renal function and hydration status, the most appropriate treatment is to discontinue the IV administration of crystalloid solutions with a low effective SID, such as 0.9%NaCl. For hyperchloremic acidosis in critically ill patients, the most appropriate treatment is to commence the IV administration of a crystalloid solution with a high effective SID, such as sodium bicarbonate or THAM. References
This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|